₹ 807.00
10.40 (1.31%)
N
Natco Pharma
₹ 807.00
Natco Pharma Fundamentals
Company Valuation
Market Cap (₹ Cr.)
15,831
PE Ratio
13.60
PB Ratio
1.49
Dividend Yield
0.19%
ROE
14.88%
ROCE
16.26%
Book Value (₹)
535.28
Face Value (₹)
2.00
Analyse NATCOPHARM with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Oct 2026 |
|---|---|---|---|---|---|
| Promoters | 49.48% | 49.42% | 49.42% | 49.39% | 46.22% |
| Domestic Institutional Investors (DII) | 5.39% | 5.46% | 5.62% | 6.16% | 10.82% |
| Foreign Institutional Investors (FII) | 15.16% | 17.37% | 16.99% | 16.00% | 15.36% |
| Public Investors | 25.38% | 23.34% | 23.41% | 23.85% | 22.78% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
NATCOPHARM Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Smallcap
BSE Scrip Code
524816
NSE Scrip Name
NATCOPHARM
ISIN
INE987B01026
Part of Indices

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






